Blog

(MEMPHIS, Tenn. – May 03, 2024) Targeting anti-cancer therapy to affect cancer cells but not healthy cells is challenging. For chimeric antigen receptor (CAR) T–cell immunotherapy, where a patient’s own immune cells are re-engineered to attack cancer cells, many solid and brain cancers lack an

PHILADELPHIA — (May 3, 2024) — The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune system so that the tumor can grow unimpeded by

Study Title: Efficacy of [177Lu]Lu-PSMA-617 versus ARPI change in taxane-naive patients with metastatic castration-resistant prostate cancer by pre-randomization ARPI (PSMAfore) Credit: Dana-Farber Cancer Institute Study Title: Efficacy of [177Lu]Lu-PSMA-617 versus ARPI change in taxane-naive patients with metastatic castration-resistant prostate cancer by pre-randomization ARPI (PSMAfore) Publication:

Researchers at Umeå University, Sweden, have discovered that how a special protein complex called the Mediator moves along genes in DNA may have an impact on how cells divide. The discovery may be important for future research into the treatment of certain diseases. Credit: Johan

MADISON — Many pancreatic tumors are like malignant fortresses, surrounded by a dense matrix of collagen and other tissue that shields them from immune cells and immunotherapies that have been effective in treating other cancers. Employing bacteria to infiltrate that cancerous fortification and deliver these

Mary Ann Liebert, Inc., is pleased that Andrei Moroz, PhD, has been appointed the new Deputy Editor-in-Chief of the bimonthly journal Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. Dr. Moroz is joining Cory Brooks, PhD, as part of the senior editorial leadership team for the journal.

Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many times, a hallmark of cancer cells. Credit: Sergi Regot lab, Johns Hopkins Medicine

Successful surgery  Credit: UZ Brussel Successful surgery  During the surgery Wednesday April 17, the Da Vinci Xi surgical system was combined with MMI’s Symani surgical system. In collaboration with abdominal surgeon Dr Martijn Schoneveld, the plastic and reconstructive surgery team performed a fully robotic lymph node

HOUSTON ― For most smokers, quitting on the first attempt is likely to be unsuccessful, but a new study from The University of Texas MD Anderson Cancer Center found patients were more likely to quit if their cessation regimen was altered and doses were increased.

Genetics can be associated with one’s behavior and health—from the willingness to take risks, and how long one stays in school, to chances of developing Alzheimer’s disease and breast cancer. Although our fate is surely not written in our genes, corporations may still find genetic